Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols
<p>Abstract</p> <p>Variability in the subfertile patient population excludes the possibility of a single approach to controlled ovarian stimulation (COS) covering all the requirements of a patient. Modern technology has led to the development of new drugs, treatment options and qua...
Main Authors: | Alviggi Carlo, Humaidan Peter, Ezcurra Diego |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-02-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | http://www.rbej.com/content/10/1/9 |
Similar Items
-
Investigating the association between polymorphism of follicle-stimulating hormone receptor gene and ovarian response in controlled ovarian hyperstimulation
by: Mohammad Hasan Sheikhha, et al.
Published: (2011-01-01) -
Anti-müllerian Hormone for the Prediction of Ovarian Response in Progestin-Primed Ovarian Stimulation Protocol for IVF
by: Jialyu Huang, et al.
Published: (2019-05-01) -
Impact of Laparoscopic Ovarian Cystectomy on Serum Follicle Stimulating Hormone
by: Shazia Hanif, et al.
Published: (2019-08-01) -
Effect of progestin-primed ovarian stimulation protocol in infertile women with basal follicle-stimulating hormone levels ≥15 IU/L: A retrospective analysis
by: Lu Fang, et al.
Published: (2020-01-01) -
The Ovarian Sensitivity Index (OSI) Significantly Correlates with Ovarian Reserve Biomarkers, Is More Predictive of Clinical Pregnancy than the Total Number of Oocytes, and Is Consistent in Consecutive IVF Cycles
by: Alberto Revelli, et al.
Published: (2020-06-01)